US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Palisade Bio Inc.

0.6405

-0.0035-0.54%

Post-market: 0.6301-0.0104-1.62%19:58 EDT

Volume:122.95K

Turnover:79.15K

Market Cap:3.07M

PE:-0.06

High:0.6629

Open:0.6400

Low:0.6350

Close:0.6440

Loading ...

Overview Company News Filings

Palisade Bio Inc: Files for Offering of Upto 13.1 Mln Shares of Common Stock

THOMSON REUTERS

Palisade Bio Inc - Phase 1 Program Meets Primary Endpoints of Safety, Tolerability, and Pk

THOMSON REUTERS

Palisade Bio Reports Positive Phase 1a Results for Pali-2108, a First-in-Class Terminal Ileum and Colon-Targeted Pde4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

THOMSON REUTERS

Palisade Bio Inc - No Serious Adverse Events Observed in Phase 1 Studies

THOMSON REUTERS

Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating

Palisade Bio Is Maintained at Buy by Brookline Capital

Palisade Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Palisade Bio Q1 EPS $(0.47) Beats $(0.70) Estimate

Palisade Bio Inc expected to post a loss of 70 cents a share - Earnings Preview

Palisade Bio Inc. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement

Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108

BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108

Palisade Bio Inc - to Report Topline Data From Phase 1a Study by End of May 2025

THOMSON REUTERS

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences

Palisade Bio Inc expected to post a loss of $1.99 a share - Earnings Preview

Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial

MT Newswires Live

Palisade Bio: No Serious Adverse Events & No Treatment-Emergent Adverse Events Related to Laboratory Values or Ekgs Seen to Date

THOMSON REUTERS

Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/B Study of Pali-2108

THOMSON REUTERS

Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PALI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PALI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":0.6405,"timestamp":1750276800000,"preClose":0.644,"halted":0,"volume":122953,"hourTrading":{"tag":"盘后","latestPrice":0.6301,"preClose":0.6405,"latestTime":"19:58 EDT","volume":30146,"amount":19051.0816,"timestamp":1750291135275},"delay":0,"floatShares":4488300,"shares":4795646,"eps":-10.192937,"marketStatus":"Closed Juneteenth National Independence Day","change":-0.0035,"latestTime":"06-18 16:00:00 EDT","open":0.64,"high":0.6629,"low":0.635,"amount":79153.83888242,"amplitude":0.043323,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.192937,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":7,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":0.644,"preHourTrading":{"tag":"盘前","latestPrice":0.6699,"preClose":0.644,"latestTime":"09:29 EDT","volume":3130,"amount":2118.848492,"timestamp":1750253351988},"postHourTrading":{"tag":"盘后","latestPrice":0.6301,"preClose":0.6405,"latestTime":"19:58 EDT","volume":30146,"amount":19051.0816,"timestamp":1750291135275},"volumeRatio":0.15083893832932727},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","floatShares":4488300,"roa":"-80.94%","roe":"-170.72%","lyrEps":-10.192937,"volumeRatio":0.15083893832932727,"shares":4795646,"dividePrice":0,"high":0.6629,"amplitude":0.043323,"preClose":0.644,"low":0.635,"week52Low":0.6,"pbRate":"0.58","week52High":5.15,"institutionHeld":0.0656,"latestPrice":0.6405,"eps":-10.192937,"divideRate":0,"volume":122953,"delay":0,"ttmEps":-10.192937,"open":0.64,"prevYearClose":1.65,"prevWeekClose":0.6401,"prevMonthClose":0.742,"prevQuarterClose":0.6808,"fiveDayClose":0.6552,"twentyDayClose":0.7369,"sixtyDayClose":0.701},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PALI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538469179","title":"Palisade Bio Inc: Files for Offering of Upto 13.1 Mln Shares of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2538469179","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538469179?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:50","pubTimestamp":1748350224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RZ1HA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4139","BK4007"],"gpt_icon":0},{"id":"2538946677","title":"Palisade Bio Inc - Phase 1 Program Meets Primary Endpoints of Safety, Tolerability, and Pk","url":"https://stock-news.laohu8.com/highlight/detail?id=2538946677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538946677?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:30","pubTimestamp":1748349000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nTUA5D2T2N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"2538466777","title":"Palisade Bio Reports Positive Phase 1a Results for Pali-2108, a First-in-Class Terminal Ileum and Colon-Targeted Pde4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2538466777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538466777?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:30","pubTimestamp":1748349000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nTUA5D2T2N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PALI","BK4139"],"gpt_icon":0},{"id":"2538466091","title":"Palisade Bio Inc - No Serious Adverse Events Observed in Phase 1 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2538466091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538466091?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:30","pubTimestamp":1748349000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nTUA5D2T2N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2536347359","title":"Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2536347359","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536347359?lang=en_us&edition=fundamental","pubTime":"2025-05-17 03:25","pubTimestamp":1747423516,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Palisade Bio (PALI – Research Report), with a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/palisade-bios-pali-2108-promising-phase-1-results-and-strategic-positioning-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/palisade-bios-pali-2108-promising-phase-1-results-and-strategic-positioning-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI"],"gpt_icon":0},{"id":"2535083081","title":"Palisade Bio Is Maintained at Buy by Brookline Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2535083081","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535083081?lang=en_us&edition=fundamental","pubTime":"2025-05-14 02:34","pubTimestamp":1747161240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PALI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2025 14:34 ET (18:34 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BRKL"],"gpt_icon":0},{"id":"2535706701","title":"Palisade Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535706701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535706701?lang=en_us&edition=fundamental","pubTime":"2025-05-13 23:43","pubTimestamp":1747151022,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc reports results for the quarter ended March 31 - Earnings SummaryPalisade Bio Inc PALI.OQ reported a quarterly adjusted loss of 47 cents per share for the quarter ended March 31, high","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL25R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":0},{"id":"2535780752","title":"Palisade Bio Q1 EPS $(0.47) Beats $(0.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535780752","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535780752?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:34","pubTimestamp":1747085658,"startTime":"0","endTime":"0","summary":"Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.70) by 32.86 percent. This is a 89.76 percent increase over losses of $(4.59) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45362786/palisade-bio-q1-eps-0-47-beats-0-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":0},{"id":"2534343115","title":"Palisade Bio Inc  expected to post a loss of 70 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534343115","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534343115?lang=en_us&edition=fundamental","pubTime":"2025-05-09 23:16","pubTimestamp":1746803780,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc  expected to post a loss of70cents a share - Earnings Preview Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports  results on May 12 (es","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":0},{"id":"2532043872","title":"Palisade Bio Inc. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2532043872","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532043872?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:13","pubTimestamp":1746216824,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc. has announced that it received a notice from The Nasdaq Stock Market LLC regarding non-compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company's common stock has closed below the $1.00 per share minimum for 30 consecutive trading days. Currently, the listing of Palisade Bio's common stock remains unaffected, and it continues to trade under the symbol \"PALI.\" The company now has 180 calendar days to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. If necessary, an additional 180-day period may be granted, provided other listing standards are met. Palisade Bio is monitoring the situation and may explore options to address the deficiency.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nNDL6LCwV8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2526366631","title":"Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366631","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366631?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:36","pubTimestamp":1744202180,"startTime":"0","endTime":"0","summary":"Palisade Bio (PALI) announced the completion of enrollment and dosing in all five Phase 1a SAD cohorts, all four MAD cohorts, and the food effects ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-completes-dosing-in-phase-1b-portion-of-phase-1a-1n-study-of-pali-2108?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-completes-dosing-in-phase-1b-portion-of-phase-1a-1n-study-of-pali-2108?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2526736500","title":"BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526736500","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526736500?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:35","pubTimestamp":1744202143,"startTime":"0","endTime":"0","summary":"BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108April 9 (Reuters) - Palisade Bio Inc PALI.O:PALISADE BIO COMPLETES DOSING IN PHASE 1A PORTION OF ONGOING","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2526365789","title":"Palisade Bio Inc - to Report Topline Data From Phase 1a Study by End of May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526365789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526365789?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN0W7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2526366885","title":"Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366885","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366885?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201800,"startTime":"0","endTime":"0","summary":"Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, further supporting the safety and tolerab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058394/0/en/Palisade-Bio-Completes-Dosing-in-Phase-1a-Portion-of-Ongoing-Phase-1a-b-Study-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4534","BK4198","BK4007","ALC","BK4139","LU1804176565.USD","LU2265009873.SGD"],"gpt_icon":0},{"id":"2522617819","title":"U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2522617819","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522617819?lang=en_us&edition=fundamental","pubTime":"2025-03-26 15:46","pubTimestamp":1742975171,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences March 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3N3Q90KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","LU2065170008.USD","CNOB","LU2089279066.USD","LU0266013472.USD","COTY","BK4139","LU2125910336.SGD","LU2065171311.SGD","BK4104","LU2125910179.SGD","BK4539","IE0002270589.USD","IE00B19Z3581.USD","LU2087625088.SGD","LU0823416689.USD","WLK","LU0823411888.USD","NBIX","IE00B19Z4B17.USD","IE0031619046.USD","KBH","IE00B7SZLL34.SGD","ULTA","IE00B7SZL793.SGD","LU0029874061.USD","PZZA","BK4200","SUN","BK4585","BK4590","PALI","CNM","BK4183","CRNX","BK4077","FRPT","CRMD","BK4516","IE00B19Z3B42.SGD","LAKE","LU0889565916.HKD","LU2229751404.USD","LU2065171402.SGD","RUM","ASH","LU0353189680.USD","LU2463526074.USD","BK4090","LU0053671581.USD"],"gpt_icon":0},{"id":"2521289492","title":"Palisade Bio Inc  expected to post a loss of $1.99 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289492","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289492?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:03","pubTimestamp":1742562198,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc  expected to post a loss of $1.99 a share - Earnings Preview Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports  results on March 25 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q415K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":1},{"id":"2519730809","title":"Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519730809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519730809?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:57","pubTimestamp":1741957023,"startTime":"0","endTime":"0","summary":"Palisade Bio  said Friday it began dosing ulcerative colitis patients in the final cohort of its phase 1a/b study of PALI-2108.The company said it had completed five single ascending dose cohorts and three of four multiple ascending dose cohorts, with no serious adverse events or treatment-related adverse events tied to lab results or EKGs.Palisade Bio said it plans to report topline data in H1.Shares of the company were up 3% in recent Friday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PALI","BK4139","BK4007"],"gpt_icon":1},{"id":"2519806520","title":"Palisade Bio: No Serious Adverse Events & No Treatment-Emergent Adverse Events Related to Laboratory Values or Ekgs Seen to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806520","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806520?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955431,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0PM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2519065378","title":"Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/B Study of Pali-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2519065378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519065378?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955431,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2519061888","title":"Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2519061888","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519061888?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955400,"startTime":"0","endTime":"0","summary":"Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and tolerability of PALI-2108 No serious adve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/14/3042967/0/en/Palisade-Bio-Commences-Dosing-in-First-Ulcerative-Colitis-Patient-Cohort-in-Ongoing-Phase-1a-b-Study-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4534","BK4198","BK4007","LU1804176565.USD","BK4139","ALC","LU2265009873.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PALI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"PALI","fiscalQuarterEnding":"2025/03","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-03-24","symbol":"PALI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2024-11-12","symbol":"PALI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-2.32},{"date":"2024-08-13","symbol":"PALI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723536000000,"name":null,"time":"Pre-Market","dateTimestamp":1723521600000,"actualEps":null},{"date":"2024-05-14","symbol":"PALI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"Pre-Market","dateTimestamp":1715659200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PALI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PALI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PALI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PALI","date":"2025-06-18","current":-0.23502,"percent":0.815524,"low":-8.398968,"twenty":-0.832922,"median":-0.402754,"eighty":-0.249392,"high":5.714804,"avg":-0.449183,"sd":1.294772,"marketCap":3088396},"quantilePoints":[{"date":"2021-04-30","current":-6.235722,"twenty":-7.595945,"median":-6.39141,"eighty":-6.297997,"marketCap":55734879},{"date":"2021-05-07","current":-4.877259,"twenty":-6.329135,"median":-5.199166,"eighty":-4.928997,"marketCap":43592940},{"date":"2021-05-14","current":-3.071774,"twenty":-5.894847,"median":-4.877259,"eighty":-4.31519,"marketCap":27455520},{"date":"2021-05-21","current":-3.088114,"twenty":-5.23604,"median":-4.366658,"eighty":-3.120792,"marketCap":27601560},{"date":"2021-05-28","current":-3.112623,"twenty":-5.01152,"median":-3.758022,"eighty":-3.016221,"marketCap":27820620},{"date":"2021-06-04","current":-3.088114,"twenty":-4.980735,"median":-3.235167,"eighty":-3.058703,"marketCap":27601560},{"date":"2021-06-11","current":-3.357711,"twenty":-4.834777,"median":-3.235167,"eighty":-3.075042,"marketCap":30011220},{"date":"2021-06-18","current":-3.37405,"twenty":-4.607662,"median":-3.316863,"eighty":-3.088114,"marketCap":30157260},{"date":"2021-06-25","current":-3.58646,"twenty":-4.374011,"median":-3.345457,"eighty":-3.091382,"marketCap":32055780},{"date":"2021-07-02","current":-2.965569,"twenty":-4.341333,"median":-3.341372,"eighty":-3.091382,"marketCap":26506260},{"date":"2021-07-09","current":-3.096283,"twenty":-4.289047,"median":-3.316863,"eighty":-3.071774,"marketCap":27674580},{"date":"2021-07-16","current":-2.056128,"twenty":-3.758022,"median":-3.239251,"eighty":-2.990078,"marketCap":24607740},{"date":"2021-07-23","current":-2.074432,"twenty":-3.59463,"median":-3.210658,"eighty":-2.883873,"marketCap":24826800},{"date":"2021-07-30","current":-1.787672,"twenty":-3.58646,"median":-3.198403,"eighty":-2.373394,"marketCap":21394860},{"date":"2021-08-06","current":-1.647343,"twenty":-3.553782,"median":-3.112623,"eighty":-2.123242,"marketCap":19715400},{"date":"2021-08-13","current":-1.58633,"twenty":-3.463916,"median":-3.092199,"eighty":-2.074432,"marketCap":18985200},{"date":"2021-08-20","current":-1.549723,"twenty":-3.447577,"median":-3.071774,"eighty":-1.928001,"marketCap":18547080},{"date":"2021-08-27","current":-0.68888,"twenty":-3.431237,"median":-2.990078,"eighty":-1.683951,"marketCap":28838584},{"date":"2021-09-03","current":-0.743337,"twenty":-3.431237,"median":-2.965569,"eighty":-1.659545,"marketCap":31118314},{"date":"2021-09-10","current":-0.816854,"twenty":-3.392023,"median":-2.932891,"eighty":-1.582669,"marketCap":34195950},{"date":"2021-09-17","current":-0.74606,"twenty":-3.375684,"median":-2.859364,"eighty":-1.503353,"marketCap":31232301},{"date":"2021-09-24","current":-0.658929,"twenty":-3.360979,"median":-2.373394,"eighty":-0.786902,"marketCap":27584733},{"date":"2021-10-01","current":-0.677989,"twenty":-3.351175,"median":-2.205609,"eighty":-0.760763,"marketCap":28382638},{"date":"2021-10-08","current":-0.756712,"twenty":-3.343006,"median":-2.123242,"eighty":-0.751505,"marketCap":31678255},{"date":"2021-10-15","current":-0.85246,"twenty":-3.3283,"median":-2.086634,"eighty":-0.753683,"marketCap":35686524},{"date":"2021-10-22","current":-0.80613,"twenty":-3.318497,"median":-2.056128,"eighty":-0.756215,"marketCap":33747039},{"date":"2021-10-29","current":-0.846283,"twenty":-3.303792,"median":-1.860887,"eighty":-0.76126,"marketCap":35427926},{"date":"2021-11-05","current":-0.880257,"twenty":-3.254774,"median":-1.683951,"eighty":-0.762791,"marketCap":36850215},{"date":"2021-11-12","current":-1.134957,"twenty":-3.236801,"median":-1.674799,"eighty":-0.764674,"marketCap":36242580},{"date":"2021-11-19","current":-1.045691,"twenty":-3.235167,"median":-1.659545,"eighty":-0.782546,"marketCap":33392040},{"date":"2021-11-26","current":-0.981929,"twenty":-3.220462,"median":-1.604634,"eighty":-0.786902,"marketCap":31355940},{"date":"2021-12-03","current":-0.786393,"twenty":-3.210658,"median":-1.558874,"eighty":-0.786902,"marketCap":25111900},{"date":"2021-12-10","current":-0.892663,"twenty":-3.210658,"median":-1.507014,"eighty":-0.786902,"marketCap":28505400},{"date":"2021-12-17","current":-0.807647,"twenty":-3.195953,"median":-1.139207,"eighty":-0.786902,"marketCap":25790600},{"date":"2021-12-23","current":-0.709879,"twenty":-3.179613,"median":-1.06907,"eighty":-0.786393,"marketCap":22668580},{"date":"2021-12-31","current":-0.552601,"twenty":-3.146935,"median":-0.994681,"eighty":-0.758986,"marketCap":17646200},{"date":"2022-01-07","current":-0.565353,"twenty":-3.109355,"median":-0.984055,"eighty":-0.751505,"marketCap":18053420},{"date":"2022-01-14","current":-0.552601,"twenty":-3.101185,"median":-0.973427,"eighty":-0.743337,"marketCap":17646200},{"date":"2022-01-21","current":-0.448457,"twenty":-3.094649,"median":-0.914232,"eighty":-0.729723,"marketCap":14320570},{"date":"2022-01-28","current":-0.467585,"twenty":-3.088114,"median":-0.892637,"eighty":-0.708328,"marketCap":14931400},{"date":"2022-02-04","current":-0.393367,"twenty":-3.084846,"median":-0.884161,"eighty":-0.689425,"marketCap":12561379},{"date":"2022-02-11","current":-0.429328,"twenty":-3.068506,"median":-0.872535,"eighty":-0.671031,"marketCap":13709740},{"date":"2022-02-18","current":-0.403016,"twenty":-3.042364,"median":-0.855548,"eighty":-0.659474,"marketCap":12869509},{"date":"2022-02-25","current":-0.391071,"twenty":-2.990078,"median":-0.850155,"eighty":-0.641867,"marketCap":12488080},{"date":"2022-03-04","current":-0.393154,"twenty":-2.990078,"median":-0.849371,"eighty":-0.599359,"marketCap":12554592},{"date":"2022-03-11","current":-0.442081,"twenty":-2.990078,"median":-0.849371,"eighty":-0.582356,"marketCap":14116960},{"date":"2022-03-18","current":-0.602849,"twenty":-2.965569,"median":-0.844549,"eighty":-0.565353,"marketCap":16045436},{"date":"2022-03-25","current":-0.801515,"twenty":-2.965569,"median":-0.837017,"eighty":-0.565353,"marketCap":21333136},{"date":"2022-04-01","current":-0.712458,"twenty":-2.932891,"median":-0.829295,"eighty":-0.573855,"marketCap":18962788},{"date":"2022-04-08","current":-0.650735,"twenty":-2.883873,"median":-0.816854,"eighty":-0.582356,"marketCap":17319954},{"date":"2022-04-14","current":-0.637102,"twenty":-2.870802,"median":-0.811898,"eighty":-0.585757,"marketCap":16957108},{"date":"2022-04-22","current":-0.615317,"twenty":-2.854463,"median":-0.806889,"eighty":-0.593409,"marketCap":16377284},{"date":"2022-04-29","current":-0.534344,"twenty":-2.831588,"median":-0.794895,"eighty":-0.573762,"marketCap":14222091},{"date":"2022-05-06","current":-0.422789,"twenty":-2.464052,"median":-0.788264,"eighty":-0.559402,"marketCap":11252961},{"date":"2022-05-13","current":-0.412841,"twenty":-2.329465,"median":-0.786902,"eighty":-0.547771,"marketCap":11060415},{"date":"2022-05-20","current":-0.424683,"twenty":-2.235505,"median":-0.786393,"eighty":-0.513494,"marketCap":11377678},{"date":"2022-05-27","current":-0.418149,"twenty":-2.200118,"median":-0.76512,"eighty":-0.503186,"marketCap":11202636},{"date":"2022-06-03","current":-0.444937,"twenty":-2.152528,"median":-0.762397,"eighty":-0.476087,"marketCap":11920305},{"date":"2022-06-10","current":-0.438567,"twenty":-2.123242,"median":-0.758562,"eighty":-0.466914,"marketCap":11749640},{"date":"2022-06-17","current":-0.367514,"twenty":-2.11226,"median":-0.754228,"eighty":-0.451634,"marketCap":9846067},{"date":"2022-06-24","current":-0.366126,"twenty":-2.102498,"median":-0.751505,"eighty":-0.445495,"marketCap":9808871},{"date":"2022-07-01","current":-0.325781,"twenty":-2.089075,"median":-0.746385,"eighty":-0.44007,"marketCap":8727991},{"date":"2022-07-08","current":-0.400264,"twenty":-2.071991,"median":-0.743612,"eighty":-0.43499,"marketCap":10723461},{"date":"2022-07-15","current":-0.383848,"twenty":-2.061009,"median":-0.737891,"eighty":-0.428094,"marketCap":10283670},{"date":"2022-07-22","current":-0.363839,"twenty":-2.043925,"median":-0.728361,"eighty":-0.424683,"marketCap":9747606},{"date":"2022-07-29","current":-0.315572,"twenty":-1.981692,"median":-0.721554,"eighty":-0.420835,"marketCap":8454489},{"date":"2022-08-05","current":-0.423458,"twenty":-1.901155,"median":-0.712458,"eighty":-0.418084,"marketCap":11344857},{"date":"2022-08-12","current":-0.570101,"twenty":-1.792553,"median":-0.709879,"eighty":-0.416508,"marketCap":15273575},{"date":"2022-08-19","current":4.414871,"twenty":-1.766928,"median":-0.701936,"eighty":-0.411475,"marketCap":11527227},{"date":"2022-08-26","current":4.512979,"twenty":-1.683951,"median":-0.68888,"eighty":-0.405749,"marketCap":11783387},{"date":"2022-09-02","current":4.029939,"twenty":-1.682731,"median":-0.683343,"eighty":-0.400558,"marketCap":10522170},{"date":"2022-09-09","current":4.038124,"twenty":-1.677849,"median":-0.676931,"eighty":-0.398303,"marketCap":10543542},{"date":"2022-09-16","current":3.819847,"twenty":-1.671748,"median":-0.667097,"eighty":-0.394592,"marketCap":9973621},{"date":"2022-09-23","current":3.113175,"twenty":-1.671748,"median":-0.660291,"eighty":-0.391921,"marketCap":8128501},{"date":"2022-09-30","current":2.701177,"twenty":-1.659545,"median":-0.650735,"eighty":-0.39079,"marketCap":7052774},{"date":"2022-10-07","current":2.709363,"twenty":-1.647343,"median":-0.642122,"eighty":-0.38563,"marketCap":7074146},{"date":"2022-10-14","current":2.589311,"twenty":-1.604634,"median":-0.637102,"eighty":-0.373068,"marketCap":6760690},{"date":"2022-10-21","current":2.837601,"twenty":-1.58633,"median":-0.630286,"eighty":-0.367514,"marketCap":7408975},{"date":"2022-10-28","current":2.589311,"twenty":-1.568026,"median":-0.61381,"eighty":-0.365524,"marketCap":6760690},{"date":"2022-11-04","current":2.335563,"twenty":-1.549723,"median":-0.605735,"eighty":-0.361316,"marketCap":6098156},{"date":"2022-11-11","current":2.23461,"twenty":-1.53752,"median":-0.602301,"eighty":-0.35118,"marketCap":5834568},{"date":"2022-11-18","current":-0.398957,"twenty":-1.507014,"median":-0.597644,"eighty":-0.35538,"marketCap":3776927},{"date":"2022-11-25","current":-0.610649,"twenty":-1.492371,"median":-0.60083,"eighty":-0.357408,"marketCap":5781011},{"date":"2022-12-02","current":-0.69044,"twenty":-1.212508,"median":-0.602849,"eighty":-0.359061,"marketCap":6536396},{"date":"2022-12-09","current":-0.498289,"twenty":-1.136657,"median":-0.60083,"eighty":-0.35977,"marketCap":4717305},{"date":"2022-12-16","current":-0.381045,"twenty":-1.083947,"median":-0.59593,"eighty":-0.361028,"marketCap":3607351},{"date":"2022-12-23","current":-0.311024,"twenty":-1.067795,"median":-0.594423,"eighty":-0.354976,"marketCap":2944461},{"date":"2022-12-30","current":-0.846766,"twenty":-1.054193,"median":-0.590172,"eighty":-0.352489,"marketCap":8016335},{"date":"2023-01-06","current":-0.785441,"twenty":-1.058443,"median":-0.595109,"eighty":-0.354169,"marketCap":7435768},{"date":"2023-01-13","current":-1.118311,"twenty":-1.058443,"median":-0.597622,"eighty":-0.356394,"marketCap":10587051},{"date":"2023-01-20","current":-0.996847,"twenty":-1.067829,"median":-0.602301,"eighty":-0.358201,"marketCap":9437147},{"date":"2023-01-27","current":-0.938209,"twenty":-1.066328,"median":-0.605735,"eighty":-0.359453,"marketCap":8882021},{"date":"2023-02-03","current":-1.143442,"twenty":-1.078731,"median":-0.610649,"eighty":-0.360164,"marketCap":10824963},{"date":"2023-02-10","current":-0.967528,"twenty":-1.070566,"median":-0.618682,"eighty":-0.361739,"marketCap":9159584},{"date":"2023-02-17","current":-0.967528,"twenty":-1.067829,"median":-0.630252,"eighty":-0.363512,"marketCap":9159584},{"date":"2023-02-24","current":-0.904701,"twenty":-1.066945,"median":-0.631818,"eighty":-0.363839,"marketCap":8564806},{"date":"2023-03-03","current":-0.900513,"twenty":-1.063862,"median":-0.637102,"eighty":-0.363839,"marketCap":8525154},{"date":"2023-03-10","current":-0.846063,"twenty":-1.045691,"median":-0.641867,"eighty":-0.365524,"marketCap":8009679},{"date":"2023-03-17","current":-0.795802,"twenty":-1.030354,"median":-0.647255,"eighty":-0.365881,"marketCap":7533857},{"date":"2023-03-24","current":-0.517989,"twenty":-1.005224,"median":-0.646473,"eighty":-0.365962,"marketCap":7386522},{"date":"2023-03-31","current":-1.111781,"twenty":-1.005224,"median":-0.644425,"eighty":-0.366126,"marketCap":15853999},{"date":"2023-04-06","current":-0.688546,"twenty":-1.01025,"median":-0.647255,"eighty":-0.367236,"marketCap":9818669},{"date":"2023-04-14","current":-0.713644,"twenty":-1.001873,"median":-0.652987,"eighty":-0.368102,"marketCap":10176564},{"date":"2023-04-21","current":-0.654174,"twenty":-1.001035,"median":-0.65541,"eighty":-0.369295,"marketCap":9328517},{"date":"2023-04-28","current":-0.737945,"twenty":-1.001035,"median":-0.654615,"eighty":-0.371189,"marketCap":10523092},{"date":"2023-05-05","current":-0.628469,"twenty":-0.997685,"median":-0.65541,"eighty":-0.372642,"marketCap":8961974},{"date":"2023-05-12","current":-0.656852,"twenty":-0.995114,"median":-0.654615,"eighty":-0.373035,"marketCap":9366708},{"date":"2023-05-19","current":-0.732361,"twenty":-0.993063,"median":-0.656852,"eighty":-0.374309,"marketCap":9077612},{"date":"2023-05-25","current":-0.676384,"twenty":-0.991322,"median":-0.659918,"eighty":-0.377706,"marketCap":8383782},{"date":"2023-06-02","current":-0.778028,"twenty":-0.988731,"median":-0.663013,"eighty":-0.380276,"marketCap":9643654},{"date":"2023-06-09","current":-0.869878,"twenty":-0.98448,"median":-0.667097,"eighty":-0.382166,"marketCap":10782141},{"date":"2023-06-15","current":-0.875281,"twenty":-0.981929,"median":-0.67307,"eighty":-0.384204,"marketCap":10849110},{"date":"2023-06-23","current":-0.923908,"twenty":-0.981929,"median":-0.674471,"eighty":-0.385274,"marketCap":11451839},{"date":"2023-06-30","current":-0.864475,"twenty":-0.980827,"median":-0.677186,"eighty":-0.386075,"marketCap":10715171},{"date":"2023-07-07","current":-0.950923,"twenty":-0.97876,"median":-0.681631,"eighty":-0.386553,"marketCap":11786688},{"date":"2023-07-14","current":-1.102206,"twenty":-0.981929,"median":-0.685714,"eighty":-0.387278,"marketCap":13661843},{"date":"2023-07-21","current":-1.085997,"twenty":-0.98788,"median":-0.687352,"eighty":-0.387446,"marketCap":13460933},{"date":"2023-07-28","current":-1.167042,"twenty":-0.998522,"median":-0.69044,"eighty":-0.387685,"marketCap":14465481},{"date":"2023-08-04","current":-1.123818,"twenty":-1.015276,"median":-0.695051,"eighty":-0.389582,"marketCap":13929722},{"date":"2023-08-11","current":-0.372805,"twenty":-1.046685,"median":-0.69506,"eighty":-0.389582,"marketCap":4620917},{"date":"2023-08-18","current":-0.316168,"twenty":-1.036489,"median":-0.691021,"eighty":-0.386075,"marketCap":4250561},{"date":"2023-08-25","current":-0.316168,"twenty":-1.015276,"median":-0.688546,"eighty":-0.377706,"marketCap":4250561},{"date":"2023-09-01","current":-0.347683,"twenty":-1.002711,"median":-0.685385,"eighty":-0.372322,"marketCap":4674246},{"date":"2023-09-08","current":-0.397658,"twenty":-1.001035,"median":-0.683343,"eighty":-0.370372,"marketCap":5346109},{"date":"2023-09-15","current":-0.424944,"twenty":-1.001035,"median":-0.677186,"eighty":-0.371839,"marketCap":5712941},{"date":"2023-09-19","current":-0.414479,"twenty":-1.001035,"median":-0.676384,"eighty":-0.37208,"marketCap":5572256},{"date":"2023-09-29","current":-0.368654,"twenty":-1.001035,"median":-0.674471,"eighty":-0.368654,"marketCap":4956181},{"date":"2023-10-06","current":-0.39054,"twenty":-0.996847,"median":-0.66982,"eighty":-0.369556,"marketCap":5250426},{"date":"2023-10-13","current":-0.378092,"twenty":-0.995114,"median":-0.666828,"eighty":-0.371189,"marketCap":5083074},{"date":"2023-10-17","current":-0.411059,"twenty":-0.994276,"median":-0.664374,"eighty":-0.371839,"marketCap":5526280},{"date":"2023-11-02","current":-0.376177,"twenty":-0.993063,"median":-0.66128,"eighty":-0.372563,"marketCap":5057328},{"date":"2023-11-10","current":-0.355659,"twenty":-0.990876,"median":-0.656852,"eighty":-0.371023,"marketCap":4781473},{"date":"2023-11-17","current":-0.36942,"twenty":-0.98703,"median":-0.65541,"eighty":-0.369529,"marketCap":4820558},{"date":"2023-11-24","current":-0.413213,"twenty":-0.98448,"median":-0.654174,"eighty":-0.370164,"marketCap":5392020},{"date":"2023-12-01","current":-0.441467,"twenty":-0.981929,"median":-0.652797,"eighty":-0.371138,"marketCap":5760705},{"date":"2023-12-08","current":-0.431578,"twenty":-0.981562,"median":-0.649739,"eighty":-0.371431,"marketCap":5631665},{"date":"2023-12-15","current":-0.416816,"twenty":-0.97876,"median":-0.646473,"eighty":-0.371839,"marketCap":5439027},{"date":"2023-12-22","current":-0.420347,"twenty":-0.973249,"median":-0.644586,"eighty":-0.372825,"marketCap":5485113},{"date":"2023-12-29","current":-0.461881,"twenty":-0.972713,"median":-0.642377,"eighty":-0.372883,"marketCap":6027080},{"date":"2024-01-05","current":-0.385997,"twenty":-0.972207,"median":-0.641518,"eighty":-0.372969,"marketCap":5036876},{"date":"2024-01-12","current":-0.376548,"twenty":-0.970041,"median":-0.637102,"eighty":-0.373217,"marketCap":4913573},{"date":"2024-01-19","current":-0.376548,"twenty":-0.967528,"median":-0.633446,"eighty":-0.373143,"marketCap":4913573},{"date":"2024-01-26","current":-0.363049,"twenty":-0.96669,"median":-0.630286,"eighty":-0.372825,"marketCap":4737426},{"date":"2024-02-02","current":-0.416981,"twenty":-0.962806,"median":-0.628469,"eighty":-0.372825,"marketCap":5441185},{"date":"2024-02-09","current":-0.319738,"twenty":-0.96037,"median":-0.623231,"eighty":-0.371427,"marketCap":4172255},{"date":"2024-02-16","current":-0.314051,"twenty":-0.957505,"median":-0.61381,"eighty":-0.369425,"marketCap":4098049},{"date":"2024-02-23","current":-0.300332,"twenty":-0.950923,"median":-0.60922,"eighty":-0.368249,"marketCap":3919026},{"date":"2024-03-01","current":-0.285759,"twenty":-0.94552,"median":-0.603229,"eighty":-0.365962,"marketCap":3728872},{"date":"2024-03-08","current":-0.278224,"twenty":-0.942397,"median":-0.599359,"eighty":-0.363839,"marketCap":3630548},{"date":"2024-03-15","current":-0.261235,"twenty":-0.940117,"median":-0.595519,"eighty":-0.363404,"marketCap":3408857},{"date":"2024-03-22","current":-0.277087,"twenty":-0.938209,"median":-0.593738,"eighty":-0.36253,"marketCap":3615707},{"date":"2024-03-28","current":-0.410438,"twenty":-0.938209,"median":-0.582356,"eighty":-0.361028,"marketCap":5048382},{"date":"2024-04-05","current":-0.398186,"twenty":-0.938209,"median":-0.571746,"eighty":-0.361914,"marketCap":4897684},{"date":"2024-04-12","current":-0.303182,"twenty":-0.931507,"median":-0.565353,"eighty":-0.361028,"marketCap":3729136},{"date":"2024-04-19","current":-0.350943,"twenty":-0.929832,"median":-0.559354,"eighty":-0.359061,"marketCap":4316603},{"date":"2024-04-26","current":-0.431238,"twenty":-0.929832,"median":-0.552601,"eighty":-0.357464,"marketCap":5304228},{"date":"2024-05-03","current":-0.504611,"twenty":-0.929832,"median":-0.549758,"eighty":-0.359061,"marketCap":6206713},{"date":"2024-05-10","current":-0.480384,"twenty":-0.929415,"median":-0.546835,"eighty":-0.35977,"marketCap":5908722},{"date":"2024-05-17","current":-0.407804,"twenty":-0.929311,"median":-0.543164,"eighty":-0.361028,"marketCap":5500050},{"date":"2024-05-24","current":-0.358259,"twenty":-0.924989,"median":-0.534344,"eighty":-0.35977,"marketCap":4831834},{"date":"2024-05-31","current":-0.320072,"twenty":-0.923908,"median":-0.527464,"eighty":-0.358121,"marketCap":4316813},{"date":"2024-06-07","current":-0.325627,"twenty":-0.918102,"median":-0.520417,"eighty":-0.352702,"marketCap":4391725},{"date":"2024-06-14","current":-0.315212,"twenty":-0.913389,"median":-0.514587,"eighty":-0.349811,"marketCap":4251265},{"date":"2024-06-21","current":-0.330487,"twenty":-0.911478,"median":-0.507968,"eighty":-0.342356,"marketCap":4457273},{"date":"2024-06-28","current":-0.317295,"twenty":-0.910184,"median":-0.505842,"eighty":-0.339575,"marketCap":4279357},{"date":"2024-07-05","current":-0.30202,"twenty":-0.907214,"median":-0.504098,"eighty":-0.335275,"marketCap":4073348},{"date":"2024-07-12","current":-0.31174,"twenty":-0.904701,"median":-0.501591,"eighty":-0.330597,"marketCap":4204444},{"date":"2024-07-15","current":-0.315212,"twenty":-0.904701,"median":-0.49994,"eighty":-0.330487,"marketCap":4251265},{"date":"2024-08-02","current":-0.253419,"twenty":-0.904701,"median":-0.498289,"eighty":-0.329742,"marketCap":3417867},{"date":"2024-08-09","current":-0.252725,"twenty":-0.902443,"median":-0.487711,"eighty":-0.32575,"marketCap":3408503},{"date":"2024-08-16","current":-0.310036,"twenty":-0.900786,"median":-0.476087,"eighty":-0.322579,"marketCap":4394446},{"date":"2024-08-23","current":-0.300008,"twenty":-0.900513,"median":-0.47231,"eighty":-0.321132,"marketCap":4252308},{"date":"2024-08-30","current":-0.300843,"twenty":-0.897617,"median":-0.467585,"eighty":-0.319624,"marketCap":4264153},{"date":"2024-09-06","current":-0.306693,"twenty":-0.894355,"median":-0.465907,"eighty":-0.318303,"marketCap":4347067},{"date":"2024-09-13","current":-0.311707,"twenty":-0.892632,"median":-0.462608,"eighty":-0.317049,"marketCap":4418136},{"date":"2024-09-20","current":-0.320064,"twenty":-0.892326,"median":-0.459208,"eighty":-0.317065,"marketCap":4536585},{"date":"2024-09-27","current":-0.281623,"twenty":-0.890568,"median":-0.455058,"eighty":-0.316168,"marketCap":3991721},{"date":"2024-10-04","current":-0.297501,"twenty":-0.888577,"median":-0.448457,"eighty":-0.315212,"marketCap":4216773},{"date":"2024-10-11","current":-0.290815,"twenty":-0.887947,"median":-0.444099,"eighty":-0.313361,"marketCap":4122014},{"date":"2024-10-18","current":-0.298336,"twenty":-0.885675,"median":-0.442122,"eighty":-0.312157,"marketCap":4228618},{"date":"2024-10-25","current":-0.289144,"twenty":-0.881819,"median":-0.442081,"eighty":-0.31174,"marketCap":4098325},{"date":"2024-10-31","current":-0.259059,"twenty":-0.880257,"median":-0.44122,"eighty":-0.311068,"marketCap":3671909},{"date":"2024-11-08","current":-0.212262,"twenty":-0.878267,"median":-0.439544,"eighty":-0.310352,"marketCap":3008596},{"date":"2024-11-15","current":-0.220644,"twenty":-0.87312,"median":-0.438648,"eighty":-0.309383,"marketCap":3103355},{"date":"2024-11-22","current":-0.230645,"twenty":-0.869878,"median":-0.434565,"eighty":-0.307597,"marketCap":3244019},{"date":"2024-11-29","current":-0.232535,"twenty":-0.868865,"median":-0.433153,"eighty":-0.30673,"marketCap":3270609},{"date":"2024-12-06","current":-0.165421,"twenty":-0.864746,"median":-0.431408,"eighty":-0.304339,"marketCap":2326653},{"date":"2024-12-13","current":-0.223083,"twenty":-0.864475,"median":-0.429318,"eighty":-0.30202,"marketCap":3137657},{"date":"2024-12-20","current":-0.170148,"twenty":-0.864475,"median":-0.427619,"eighty":-0.300848,"marketCap":2393128},{"date":"2024-12-27","current":-0.167312,"twenty":-0.864475,"median":-0.427376,"eighty":-0.300008,"marketCap":2353243},{"date":"2025-01-03","current":-0.175819,"twenty":-0.862276,"median":-0.425615,"eighty":-0.298713,"marketCap":2472899},{"date":"2025-01-10","current":-0.189998,"twenty":-0.858019,"median":-0.424813,"eighty":-0.297501,"marketCap":2672327},{"date":"2025-01-17","current":-0.156914,"twenty":-0.853695,"median":-0.424683,"eighty":-0.296397,"marketCap":2206996},{"date":"2025-01-24","current":-0.139899,"twenty":-0.851577,"median":-0.423458,"eighty":-0.29497,"marketCap":1967683},{"date":"2025-01-31","current":-0.281219,"twenty":-0.850213,"median":-0.422628,"eighty":-0.294391,"marketCap":3955351},{"date":"2025-02-07","current":-0.255654,"twenty":-0.850155,"median":-0.421689,"eighty":-0.291697,"marketCap":3595774},{"date":"2025-02-14","current":-0.202557,"twenty":-0.849841,"median":-0.420673,"eighty":-0.288648,"marketCap":2848959},{"date":"2025-02-21","current":-0.192724,"twenty":-0.849371,"median":-0.420347,"eighty":-0.287568,"marketCap":2710660},{"date":"2025-02-28","current":-0.162045,"twenty":-0.849371,"median":-0.418149,"eighty":-0.286746,"marketCap":2279167},{"date":"2025-03-07","current":-0.164602,"twenty":-0.849371,"median":-0.417423,"eighty":-0.2853,"marketCap":2315125},{"date":"2025-03-14","current":-0.180433,"twenty":-0.84915,"median":-0.416981,"eighty":-0.283159,"marketCap":2537786},{"date":"2025-03-21","current":-0.154081,"twenty":-0.847966,"median":-0.416696,"eighty":-0.281643,"marketCap":2167145},{"date":"2025-03-28","current":-0.209966,"twenty":-0.846669,"median":-0.415332,"eighty":-0.281219,"marketCap":3031487},{"date":"2025-04-04","current":-0.19611,"twenty":-0.846239,"median":-0.413798,"eighty":-0.278423,"marketCap":2831440},{"date":"2025-04-11","current":-0.207073,"twenty":-0.846031,"median":-0.412841,"eighty":-0.273332,"marketCap":2989719},{"date":"2025-04-17","current":-0.213255,"twenty":-0.845904,"median":-0.412325,"eighty":-0.26877,"marketCap":3078975},{"date":"2025-04-25","current":-0.223974,"twenty":-0.843194,"median":-0.411077,"eighty":-0.265745,"marketCap":3233733},{"date":"2025-05-02","current":-0.237708,"twenty":-0.842863,"median":-0.410438,"eighty":-0.261235,"marketCap":3432021},{"date":"2025-05-09","current":-0.232927,"twenty":-0.841653,"median":-0.409293,"eighty":-0.256637,"marketCap":3362994},{"date":"2025-05-16","current":-0.227545,"twenty":-0.837686,"median":-0.408074,"eighty":-0.254212,"marketCap":2990163},{"date":"2025-05-23","current":-0.253106,"twenty":-0.837017,"median":-0.406762,"eighty":-0.253106,"marketCap":3326062},{"date":"2025-05-30","current":-0.229953,"twenty":-0.836999,"median":-0.405958,"eighty":-0.25303,"marketCap":3021814},{"date":"2025-06-06","current":-0.248267,"twenty":-0.834541,"median":-0.404031,"eighty":-0.25303,"marketCap":3262477},{"date":"2025-06-13","current":-0.251807,"twenty":-0.833584,"median":-0.403377,"eighty":-0.251713,"marketCap":3308995},{"date":"2025-06-18","current":-0.23502,"twenty":-0.832922,"median":-0.402754,"eighty":-0.249392,"marketCap":3088396}],"updateTime":1750376500354}}}